BNP Paribas Financial Markets’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.78M | Buy |
|
|||||
|
2025
Q2 | $1.38M | Buy |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $948K | Buy |
|
|||||
|
2024
Q3 | $1.25M | Sell |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.59M | Sell |
|
|||||
|
2023
Q4 | $1.72M | Buy |
|
|||||
|
2023
Q3 | $669K | Sell |
|
|||||
|
2023
Q2 | $1.15M | Sell |
|
|||||
|
2023
Q1 | $2.4M | Buy |
|
|||||
|
2022
Q4 | $757K | Sell |
|
|||||
|
2022
Q3 | $2.02M | Buy |
|
|||||
|
2022
Q2 | $481K | Sell |
|
|||||
|
2022
Q1 | $736K | Sell |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $2.97M | Buy |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2021
Q1 | $1.21M | Buy |
|
|||||
|
2020
Q4 | $445K | Buy |
|
|||||
|
2020
Q3 | $235K | Buy |
|
|||||
|
2020
Q2 | $150K | Sell |
|
|||||
|
2020
Q1 | $651K | Buy |
|
|||||
|
2019
Q4 | $585K | Buy |
|
|||||
|
2019
Q3 | $421K | Buy |
|
|||||
|
2019
Q2 | $325K | Sell |
|
|||||
|
2019
Q1 | $580K | Buy |
|
|||||
|
2018
Q4 | $59.2K | Sell |
|
|||||
|
2018
Q3 | $229K | Buy |
|
|||||
|
2018
Q2 | $149K | Sell |
|
|||||
|
2018
Q1 | $723K | Sell |
|
|||||
|
2017
Q4 | $1.01M | Sell |
|
|||||
|
2017
Q3 | $1.29M | Sell |
|
|||||
|
2017
Q2 | $1.42M | Sell |
|
|||||
|
2017
Q1 | $1.19M | Buy |
|
|||||
|
2016
Q4 | $718K | Buy |
|
|||||
|
2016
Q3 | $543K | Buy |
|
|||||
|
2016
Q2 | $612K | Buy |
|
|||||
|
2016
Q1 | $582K | Sell |
|
|||||
|
2015
Q4 | $2.08M | Buy |
|
|||||
|
2015
Q3 | $1.47M | Buy |
|
|||||
|
2015
Q2 | $1.18M | Sell |
|
|||||
|
2015
Q1 | $5.25M | Buy |
|
|||||
|
2014
Q4 | $459K | Sell |
|
|||||
|
2014
Q3 | $707K | Sell |
|
|||||
|
2014
Q2 | $1.01M | Buy |
|
|||||
|
2014
Q1 | $553K | Buy |
|
|||||
|
2013
Q4 | $262K | Buy |
|